Evidence map›Paper›PMID 41622921›Full record

ArticleJournal of cachexia, sarcopenia and muscle2026

Elevating Circulating L-Kynurenine Promotes Frailty in Aging Mice.

Mia Y Kawaida, Abigail L Tice, Samuel Alvarez, Jacob A Lackey, Benjamin Izaguirre, Qingping Yang, Lan Wei-LaPierre, Russell T Hepple, Terence E Ryan

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Elevating Circulating L-Kynurenine Promotes Frailty in Aging Mice.Journal of cachexia, sarcopenia and muscle · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mia Y KawaidaDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.
Abigail L TiceDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.
Samuel AlvarezDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.
Jacob A LackeyDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.
Benjamin IzaguirreDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.
Qingping YangDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.
Lan Wei-LaPierreDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.
Russell T HeppleMyology Institute, The University of Florida, Gainesville, Florida, USA.
Terence E RyanDepartment of Applied Physiology and Kinesiology, The University of Florida, Gainesville, Florida, USA.ORCID https://orcid.org/0000-0003-0780-029X

Funding

Linking kynurenine accumulation and the AHR pathway to exacerbated agingR01AG076490 · NIA · UNIVERSITY OF FLORIDA · PI Russell T Hepple, Terence E Ryan · 2022 to 2026
$2.5M
National Institutes of Health (NIH) R01-AG076490NIA NIH HHS R01 AG076490
6 · The paper itself

Abstract

backgroundL-Kynurenine (L-Kyn), a product of tryptophan catabolism, increases with age and has been associated with reduced physical function and increased frailty in humans. Robustly expressed in skeletal muscle, kynurenine aminotransferases (KATs) degrade L-Kyn into kynurenic acid and are regulated by the transcriptional co-regulator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α).

methodsThe study investigated (1) if elevating L-Kyn levels via a diet intervention exacerbates an age-related decline in physical, muscle and mitochondrial functions and (2) if transgenic expression of PGC1α in skeletal muscle (MCK-PGC1α) protects against age-dependent L-Kyn associated pathology in a cohort of aging MCK-PGC1α transgenic mice and their wildtype littermates of both sexes (n = 262). Physical function was assessed longitudinally from 16 to 24 months of age using treadmill endurance capacity, grip strength, walking speed and daily physical activity. Muscle function was assessed in situ using nerve-mediated contraction of the soleus muscle. Mitochondrial energetics were assessed using high resolution respirometry and fluorescence spectroscopy.

resultsMCK-PGC1α transgenic mice had significantly higher KAT expression ~2-5-fold compared with wildtype littermates (p < 0.0001 for all isoforms). A main effect of L-Kyn diet was observed for decreasing treadmill endurance capacity and daily physical activity in male mice (p ≦ 0.002). A main effect of L-Kyn diet for decreasing maximal walking speed only was found in female mice (p = 0.037). Correspondingly, L-Kyn increased frailty prevalence in male (+17%) and female (+26%) wildtype mice (p = 0.025 and 0.0001 respectively), which was mitigated by MCK-PGC1α in both sexes. Soleus muscle strength and power were not impacted by diet or genotype in either sex (p > 0.5). Mitochondrial oxidative phosphorylation function in male and female MCK-PGC1α mice was greater than wild type mice regardless of diet (p < 0.04), which is likely driven by upregulated expression of mitochondrial biogenesis related genes.

conclusionsWe conclude that PGC1α overexpression in skeletal muscle mitigates the exacerbation of physical frailty induced by elevated circulating L-Kyn in aging mice, in part through increased skeletal muscle capacity for L-Kyn metabolism due to PGC1α-induced increase in muscle KAT expression.

Indexed as

AgingFrailtyKynurenineAnimalsFemaleMaleMiceMice, TransgenicMuscle, SkeletalPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaKynureninePeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaagingfrailtymitochondriamusclephysical function

Identifiers

PMID41622921
PMCPMC12862278

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.